Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by biotech1973on Jan 07, 2020 12:45pm
219 Views
Post# 30526543

Points to consider here based on my call with Liminal

Points to consider here based on my call with Liminal
1. Their Balance sheet is amazing at this moment and they are in better position with negotatiations because they can easily fund the commercialisation 2. Last time they has almost 160million liabilities against 5 Million cash in hand. This time it is opposite. 3 Their patents were on lien against line of credit. This time company is in very good shape with lien holders now our shareholder( They are in the same boat) 4 They are listed in Nasdaq. Better exposure. 5 New CEO has a very very good resume wherein he sold previous company for 600 million
<< Previous
Bullboard Posts
Next >>